Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

thyroid cancer

  • You have access
    Management of Patients with Renal Failure Undergoing Dialysis During 131I Therapy for Thyroid Cancer
    Maximilien Vermandel, Pauline Debruyne, Amandine Beron, Laura Devos, Antoine Talbot, Jean-François Legrand, François Provôt and Georges Lion
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1161-1170; DOI: https://doi.org/10.2967/jnumed.119.232017
  • You have access
    The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
    Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li and Mingzhao Xing
    Journal of Nuclear Medicine February 1, 2020, 61 (2) 177-182; DOI: https://doi.org/10.2967/jnumed.119.227652
  • Open Access
    Enhancement of 211At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer
    Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuwei Liu, Yoshifumi Shirakami, Kazuhiro Ooe, Atsushi Toyoshima, Eku Shimosegawa, Mitsuhiro Fukuda, Atsushi Shinohara and Jun Hatazawa
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1301-1307; DOI: https://doi.org/10.2967/jnumed.118.222638
  • You have access
    Controversial Issues in Thyroid Cancer Management
    R. Michael Tuttle
    Journal of Nuclear Medicine August 1, 2018, 59 (8) 1187-1194; DOI: https://doi.org/10.2967/jnumed.117.192559
  • You have access
    Alternative Means of Estimating 131I Maximum Permissible Activity to Treat Thyroid Cancer
    Kenneth J. Nichols, William Robeson, Miyuki Yoshida-Hay, Pat B. Zanzonico, Fritzgerald Leveque, Kuldeep K. Bhargava, Gene G. Tronco and Christopher J. Palestro
    Journal of Nuclear Medicine October 1, 2017, 58 (10) 1588-1595; DOI: https://doi.org/10.2967/jnumed.117.192278
  • You have access
    Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry–Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer
    Désirée Deandreis, Carole Rubino, Hernan Tala, Sophie Leboulleux, Marie Terroir, Eric Baudin, Steve Larson, James A. Fagin, Martin Schlumberger and R. Michael Tuttle
    Journal of Nuclear Medicine May 1, 2017, 58 (5) 717-722; DOI: https://doi.org/10.2967/jnumed.116.179606
  • You have access
    High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases
    Marcus Ruhlmann, Walter Jentzen, Verena Ruhlmann, Cinzia Pettinato, Gloria Rossi, Ina Binse, Andreas Bockisch and Sandra Rosenbaum-Krumme
    Journal of Nuclear Medicine September 1, 2016, 57 (9) 1339-1342; DOI: https://doi.org/10.2967/jnumed.115.169649
  • You have access
    Risk of Breast Cancer in Patients with Thyroid Cancer Receiving or Not Receiving 131I Treatment: A Nationwide Population-Based Cohort Study
    Chun-Yi Lin, Cheng-Li Lin, Wen-Sheng Huang and Chia-Hung Kao
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 685-690; DOI: https://doi.org/10.2967/jnumed.115.164830
  • You have access
    Administration of Radioactive Iodine Therapy Within 1 Year After Total Thyroidectomy Does Not Affect Vocal Function
    Chang Hwan Ryu, Junsun Ryu, Youn Mi Ryu, You Jin Lee, Eun-Kyung Lee, Seok-Ki Kim, Tae-Sung Kim, Tae Hyun Kim, Chang Yoon Lee, Seog Yun Park, Ki Wook Chung and Yuh-S. Jung
    Journal of Nuclear Medicine October 1, 2015, 56 (10) 1480-1486; DOI: https://doi.org/10.2967/jnumed.115.161463
  • You have access
    Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An 18F-FDG PET Study
    James Nagarajah, Alan L. Ho, R. Michael Tuttle, Wolfgang A. Weber and Ravinder K. Grewal
    Journal of Nuclear Medicine May 1, 2015, 56 (5) 662-667; DOI: https://doi.org/10.2967/jnumed.114.150607

Pages

  • Next
  • 1
  • 2
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire